The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

Abstract

Circulating fibroblast growth factor 21 (FGF21) levels are often elevated in obesity, dyslipidaemia, insulin resistance and type 2 diabetes. This study investigated the relationship of plasma FGF21 levels with cardiovascular events in patients with type 2 diabetes. Plasma FGF21 levels were measured by ELISA at baseline in 9,697 individuals with type 2… (More)
DOI: 10.1007/s00125-014-3458-7

4 Figures and Tables

Topics

  • Presentations referencing similar topics